Similarly, we found that the administration of calpeptin effectively inhibited the AIM2 and NLRP3 inflammasome-mediated inflammatory response and reduced the release of IL-18 and IL-1β, suggesting that calpain may be an upstream regulator of AIM2 inflammasome during the course of acute kidney injury. This evidence concerns the gene IL1B and acute kidney injury.